tert-Butyl bromoacetate → HCID 58280086, compound
Reaction equation
[C@H:1]1([OH:8])[CH2:6][CH2:5][CH2:4][C@H:3]([OH:7])[CH2:2]1.[C:9]([O:13][C:14](=[O:17])[CH2:15]Br)([CH3:12])([CH3:11])[CH3:10]>C1COCC1.ClCCl>[C:9]([O:13][C:14](=[O:17])[CH2:15][O:7][C@H:3]1[CH2:4][CH2:5][CH2:6][C@@H:1]([OH:8])[CH2:2]1)([CH3:12])([CH3:11])[CH3:10]Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
Dissolve 5.0 g (43 mmol) of cis/trans-1,3-cyclohexanediol (approx. 1.2:1 cis/trans mixture) in 20 ml of absolute THF and, at RT, add 24.8 ml (approx. 49.5 mmol) of phosphazene base P2-t-Bu in THF (approx. 2 M solution) dropwise. Stir the solution at RT for a further 30 min and then add dropwise to a mixture of 9.5 ml (64.6 mmol) of bromoacetic acid tert-butyl ester and add 10 ml of THF dropwise. Stir the mixture at RT overnight, then dilute with dichloromethane, and wash the organic phase successively with 1N hydrochloric acid, buffer solution (pH 7) and sodium chloride solution, dry over sodium sulphate and concentrate under reduced pressure. Separate the crude product by means of chromatography on silica gel (eluent: cyclohexane/ethyl acetate 5:1→1:1). 2.73 g (27.6% of theory) of the cis-configured target compound are isolated as a pure fraction.
Workup
- stirringStir the mixture at RT overnight
- washwash the organic phase successively with 1N hydrochloric acid, buffer solution (pH 7) and sodium chloride solution
- dry with materialdry over sodium sulphate
- concentrationconcentrate under reduced pressure
- customSeparate the crude product by means of chromatography on silica gel (eluent: cyclohexane/ethyl acetate 5:1→1:1)
- custom2.73 g (27.6% of theory) of the cis-configured target compound are isolated as a pure fraction
Sources & evidence
- ORD record
- ord-97a70ecfc51842bf89cc098d85df5eff
- Source dataset
- uspto-grants-2012_12
- Patent number
- US08324222B2
Reaction notes
Loading…